EFFICACY OF INTRAVESICAL NADOFARAGENE FIRADENOVEC FOR PATIENTS WITH BCG-UNRESPONSIVE CARCINOMA IN SITU OF THE BLADDER: 36-MONTH FOLLOW-UP FROM A PHASE 3 TRIAL

被引：0

作者：

Stephen, Boorjian A.

Vikram, Narayan M.

Viraj, Master A.

Badrinath, Konety R.

Neal, Shore D.

Ashish, Kamat M.

Colin, Dinney P. N.

Trinity, Bivalacqua J.

Max, Kates R.

Jeffrey, Montgomery S.

Seth, Lerner P.

Paul, Crispen L.

Gary, Steinberg D.

Piyush, Agarwal K.

Anne, Schuckman K.

Robert, Svatek S.

Brian, Lane R.

Lawrence, Karsh, I

Marc, Bjurlin A.

Gordon, Brown A.

Yair, Lotan

Brant, Inman A.

Michael, Williams B.

Michael, Cookson S.

Sam, Chang S.

Eric, Kim H.

Alexander, Sankin, I

Michael, O'Donnell A.

Jorn, Jakobsen S.

Kristian, Juul

机构：

[1] Mayo Clin, Dept Urol, Rochester, MN USA

[2] Emory Univ, Dept Urol, Sch Med, Atlanta, GA USA

[3] Univ Minnesota, Dept Urol, Minneapolis, MN USA

[4] Allina Hlth Canc Inst, Minneapolis, MN USA

[5] Carolina Urol Res Ctr, Myrtle Beach, SC USA

[6] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX USA

[7] James Buchanan Brady Urol Inst, Johns Hopkins Sch Med, Dept Urol, Baltimore, MD USA

[8] Univ Michigan, Dept Urol, Ann Arbor, MI USA

[9] Baylor Coll Med, Scott Dept Urol, Houston, TX USA

[10] Univ Florida, Dept Urol, Gainesville, FL USA

[11] Rush Univ, Dept Urol, Chicago, IL USA

[12] Univ Chicago, Sect Urol, Dept Surg, Chicago, IL USA

[13] Univ Southern Calif, Inst Urol, Norris Comprehens Canc Ctr, Los Angeles, CA USA

[14] Univ Texas Hlth San Antonio, Dept Urol, San Antonio, TX USA

[15] Michigan State Univ, Div Urol, Spectrum Hlth, Coll Human Med, Grand Rapids, MI USA

[16] Urol Ctr Colorado, Denver, CO USA

[17] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

[18] Univ N Carolina, Dept Urol, Chapel Hill, NC USA

[19] New Jersey Urol, Bloomfield, NJ USA

[20] Univ Texas Southwestern Med Ctr, Dept Urol, Dallas, TX USA

[21] Duke Univ, Div Urol, Dept Surg, Sch Med, Durham, NC USA

[22] Urol Virginia, Virginia Beach, VA USA

[23] Univ Oklahoma, Dept Urol, Hlth Sci Ctr, Oklahoma City, OK USA

[24] Vanderbilt Univ, Div Urol Oncol, Nashville, TN USA

[25] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[26] Montefiore Med Ctr, Dept Urol, Bronx, NY USA

[27] Univ Iowa, Dept Urol, Iowa City, IA USA

[28] Ferring Pharmaceut A S, Copenhagen, Denmark

来源：

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2024年 / 42卷

关键词：

D O I：

10.1016/j.urolonc.2024.01.201

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

164

引用

页码：S70 / S70

页数：1

共 50 条

[41] Health-related quality of life in patients with metastatic Merkel cell carcinoma receiving second-line or later avelumab treatment: 36-month follow-up data
D'Angelo, S. P.
Nolte, S.
Schlichting, M.
Henry-Szatkowski, M.
Hennessy, M.
Bharmal, M.
ANNALS OF ONCOLOGY, 2019, 30 : 538 - 538
[42] Seventeen-year follow-up of the prospective randomized Nordic CIS study: BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinoma in situ of the urinary bladder
Kaasinen, Eero
Wijkstrom, Hans
Rintala, Erkki
Mestad, Oddvar
Jahnson, Staffan
Malmstrom, Per-Uno
SCANDINAVIAN JOURNAL OF UROLOGY, 2016, 50 (05) : 360 - 368
[43] External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial
Becherini, Carlotta
Meattini, Icro
Livi, Lorenzo
Garlatti, Pietro
Desideri, Isacco
Scotti, Vieri
Orzalesi, Lorenzo
Sanchez, Luis Jose
Bernini, Marco
Casella, Donato
Nesi, Silvia
Nori, Jacopo
Bianchi, Simonetta
Pallotta, Stefania
Marrazzo, Livia
TUMORI JOURNAL, 2019, 105 (03): : 205 - 209
[44] Efficacy and Safety of Three Different Treatment Regimens in De Novo Renal Transplant Patients: Month 36 Follow-Up Results of HERAKLES Trial.
Zeier, M.
Budde, K.
Arns, W.
Guba, M.
Sommerer, C.
Neumayer, H.
Jacobi, J.
Kliem, V.
Huppertz, A.
Porstner, M.
Sieder, C.
Paulus, E.
Witzke, O.
Lehner, F.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 81 - 82
[45] 36-Month Follow-up Results of the Gimema 'Veritas' Trial of Front-Line Venetoclax and Rituximab (VenR) in Young and Fit Patients with Chronic Lymphocytic Leukemia and an Adverse Biologic Profile
Mauro, Francesca Romana
Della Starza, Irene
Messina, Monica
Reda, Gianluigi
Trentin, Livio
Coscia, Marta
Sportoletti, Paolo
Orsucci, Lorella
Arena, Valentina
Gaidano, Gianluca
Marasca, Roberto
Murru, Roberta
Laurenti, Luca
Stelitano, Caterina
Mannina, Donato
Ilariucci, Fiorella
Massaia, Massimo
Rigolin, Gian Matteo
Scarfo, Lydia
Marchetti, Monia
Levato, Luciano
Tani, Monica
Arcari, Annalisa
Musuraca, Gerardo
Deodato, Marina
Galieni, Piero
Patrizi, Valeria Belsito
Gottardi, Daniela
Liberati, Anna Marina
Giordano, Annamaria
Molinari, Maria Chiara
Pepe, Sara
Andriola, Costanza
Mattiello, Veronica
Visentin, Andrea
Vitale, Candida
Albano, Francesco
Neri, Antonino
De Propris, Maria Stefania
Nanni, Mauro
Del Giudice, Ilaria
Guarini, Anna
Fazi, Paola
Vignetti, Marco
Piciocchi, Alfonso
Cuneo, Antonio
Foa, Robin
BLOOD, 2023, 142
[46] A phase III single-arm study to evaluate the efficacy and safety of paclitaxel-hyaluronic acid conjugate administered intravesically to patients with BCG-unresponsive carcinoma in situ of the bladder with or without Ta-T1 papillary disease (Orion-BC study).
Kates, Max
Bardot, Stephen
Guerrero-Ramos, Felix
Guy, Laurent
Hurle, Rodolfo
Marcq, Gautier
Moschini, Marco
Pignot, Geraldine
Porreca, Angelo
Soria, Francesco
Macchi, Alberto
Robert, Gregoire
Walczak, Rafal
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL) : TPS885 - TPS885
[47] USE OF MAINTENANCE INTRAVESICAL BACILLUS-CALMETTE-GUERIN (BCG), WITH OR WITHOUT INTRADERMAL BCG, IN PATIENTS WITH RECURRENT SUPERFICIAL BLADDER-CANCER - LONG-TERM FOLLOW-UP OF A RANDOMIZED PHASE-2 STUDY
WITJES, JA
FRANSEN, MPH
VANDERMEIJDEN, APM
DOESBURG, WH
DEBRUYNE, FMJ
UROLOGIA INTERNATIONALIS, 1993, 51 (02) : 67 - 72
[48] Green-light laser en bloc resection for primary non-muscle-invasive bladder tumor versus transurethral electroresection: A prospective, nonrandomized two-center trial with 36-month follow-up
Chen, Ji
Zhao, Yong
Wang, Sijun
Jin, Xunbo
Sun, Peng
Zhang, Longyang
Wang, Muwen
LASERS IN SURGERY AND MEDICINE, 2016, 48 (09) : 859 - 865
[49] Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart review
Yonese, Junji
Hinata, Nobuyuki
Masui, Satoru
Nakai, Yasutomo
Shirotake, Suguru
Takeuchi, Ario
Inamoto, Teruo
Nozawa, Masahiro
Ueda, Kosuke
Etsunaga, Toru
Osawa, Takahiro
Uemura, Motohide
Kimura, Go
Numakura, Kazuyuki
Yamana, Kazutoshi
Miyake, Hideaki
Fukasawa, Satoshi
Morishima, Naoto
Ito, Hiroaki
Uemura, Hirotsugu
INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (09) : 762 - 771
[50] Long-term, telephone-based follow-up after stroke and TIA improves risk factors: 36-month results from the randomized controlled NAILED stroke risk factor trial
Ogren, Joachim
Irewall, Anna-Lotta
Soderstrom, Lars
Mooe, Thomas
BMC NEUROLOGY, 2018, 18

← 1 2 3 4 5 →